ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,577Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 676

$590K Total Retail Price of All Prescriptions

Rank: 181 out of 676

534 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

36% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,981 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 698 495 S3 1 1
LEVOTHYROXINE SODIUM 679 592 2 7
OMEPRAZOLE 448 320 3 2
PRAVASTATIN SODIUM 411 354 4 11
FUROSEMIDE 408 310 5 4
AMLODIPINE BESYLATE 326 255 6 3
POTASSIUM CHLORIDE 316 264 7 9
LISINOPRIL 307 237 8 5
CLONIDINE HCL 235 169 9 32
GABAPENTIN 218 158 10 10
HYDROCHLOROTHIAZIDE 192 156 11 12
METOPROLOL TARTRATE 178 126 12 22
METFORMIN HCL ER 160 133 13 63
ZOLPIDEM TARTRATE 150 112 14 21
SIMVASTATIN 148 128 15 6
ALLOPURINOL 139 125 16 31
METOPROLOL SUCCINATE 138 106 17 14
KLOR-CON 8 133 99 18 231
BISOPROLOL-HYDROCHLOROTHIAZIDE 133 132 18 140
ISOSORBIDE MONONITRATE ER 132 100 20 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 112 21 16
CARVEDILOL 127 117 22 15
TAMSULOSIN HCL 120 96 23 38
MELOXICAM 113 93 24 13
AZITHROMYCIN 112 94 25 39
ATENOLOL 107 91 26 25
WARFARIN SODIUM 105 88 27 18
GLIPIZIDE XL 105 88 27 177
DOXYCYCLINE HYCLATE 103 76 29 82
CRESTOR 96 61 30 29
PREDNISONE 95 70 31 53
DIGOXIN 93 93 32 52
PANTOPRAZOLE SODIUM 90 55 33 42
CLOPIDOGREL 87 65 34 28
ACTOS 83 68 35 106
GEMFIBROZIL 81 80 36 137
BYSTOLIC 78 65 37 96
DONEPEZIL HCL 74 74 38 24
LOSARTAN-HYDROCHLOROTHIAZIDE 72 72 39 51
TERAZOSIN HCL 71 49 40 145
CYCLOBENZAPRINE HCL 71 40 R 40 50
LOVASTATIN 70 57 42 33
TRIAMTERENE-HCTZ 68 62 43 43
TRAMADOL HCL 67 56 44 19
POLYETHYLENE GLYCOL 3350 65 50 45 56
HYDRALAZINE HCL 65 65 45 77
METFORMIN HCL 65 45 45 8
NAMENDA 64 64 48 35
SERTRALINE HCL 63 57 49 26
VERAPAMIL ER 63 54 49 101
FLUOXETINE HCL 60 35 51 70
LEVOFLOXACIN 60 45 51 91
CIPROFLOXACIN HCL 60 45 51 45
ENALAPRIL MALEATE 57 57 54 65
SINGULAIR 56 50 55 80
CITALOPRAM HBR 53 48 56 17
HUMULIN 70-30 53 41 56 209
ZETIA 52 52 58 89
LYRICA 52 48 58 57
PLAVIX 51 36 60 40
GLIPIZIDE ER 51 33 60 103
NEXIUM 50 31 62 23
TRIAMTERENE-HYDROCHLOROTHIAZID 50 38 62 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.